Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
about
Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of PparγAn oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesionPeroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiationDeletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistancePPARs and the cardiovascular systemGenes, diet and type 2 diabetes mellitus: a reviewCandidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin actionPeroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)Pharmacogenetic studies update in type 2 diabetes mellitusIs the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?AdipogenesisPPAR-γ -- a possible drug target for complicated pregnanciesEndothelial PPAR-γ Protects Against Vascular Thrombosis by Downregulating P-Selectin ExpressionSignificanceStructural basis for the assembly of the SMRT/NCoR core transcriptional repression machineryDefining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor Ligand Binding Domain'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic StudiesRole of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cellsInhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetesPPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null miceInhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-gamma expression and adipocyte differentiationIdentification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: based on data procured from dbSNP databasePharmacogenomics in type 2 diabetes: oral antidiabetic drugs.Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In VivoConvergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acids.Investigation on the role of nsSNPs in HNPCC genes--a bioinformatics approach.Prediction of protein-destabilizing polymorphisms by manual curation with protein structure.Increased renin production in mice with deletion of peroxisome proliferator-activated receptor-gamma in juxtaglomerular cells.Meta-analysis discovery of tissue-specific DNA sequence motifs from mammalian gene expression dataDynamic regulation of Drosophila nuclear receptor activity in vivo.Adaptations to climate in candidate genes for common metabolic disordersThe genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies.It's not how fat you are, it's what you do with it that countsLigand modulated antagonism of PPARgamma by genomic and non-genomic actions of PPARdelta.Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients--EUGENE2 study.Minireview: Nuclear receptors, hematopoiesis, and stem cells.Association of genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitusEndothelial and vascular muscle PPARgamma in arterial pressure regulation: lessons from genetic interference and deficiency.A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin.The role of JAK-STAT signaling in adipose tissue function.Inverse relation between FASN expression in human adipose tissue and the insulin resistance level
P2860
Q24294883-E1E260FF-980C-4EE1-9547-ADC7737A55CCQ24300694-26A7C8AE-3145-4805-A3F2-7CA5780DA79FQ24553023-91E8ADBF-391B-443E-B3BA-E58C263F3A5DQ24555727-0346959F-9CBD-4B12-A34C-6CA3805286D8Q24642728-22FDAF49-9FBF-4222-A233-F8E98C29D4B3Q24672249-CBE30D83-2BCF-4B30-92F6-B290A794662AQ24803901-7A903381-6487-4FF4-B4FC-29A3FA99345BQ25257726-5DEAB810-2737-4FA4-8657-1E7AAE66C1C8Q26739350-4FD73A92-E289-491B-AB26-A0D654ACD4BCQ26739984-75570155-61D2-4FEC-B329-B49D730D3B9DQ26828614-C9B3110B-7727-45ED-90E5-805C31EF2EDAQ26863678-1A937A59-A122-4228-A819-B0CECDC27106Q27342480-6069EBD1-3E73-4A69-8B89-69A15D01F317Q27666601-D44D8302-65D6-4B81-9E16-6897BD8EC137Q27680515-60C68336-06D7-48E4-B3D6-3BB0340CB722Q28221639-BAC7DEFD-C170-4F61-B0C9-15BB082A4458Q28345289-0A4DB967-9183-4B96-A2CA-301F42ABB377Q28360697-B96A7312-DD3B-4816-8CB9-623AFD51947CQ28362804-829B4FF7-8ABC-4F9E-B0CE-7B930376CA96Q28507361-BE0E8C38-3C26-4BCC-8BEA-E9890FE3FA0CQ30000832-FCFA9583-EDD9-45F4-883D-8E9429742FBBQ30248914-6D14D15B-0ED7-4666-9982-D56E365F609FQ30300042-50B0DF55-0A18-4B68-8320-3AFE0471C118Q30374785-1523D8F8-5338-4087-BB07-5868565BC5BCQ30376403-87E82B52-FD2C-4D8B-ACE5-F5BDACD5198FQ30424149-49C3F683-40E4-4758-9F39-0161411CCAB5Q30433046-3024A4A0-8C3F-4481-BC4F-5A135D3A6087Q31038373-FF49AACA-985E-40EC-BE39-C2D1A9ED6DDFQ33254273-CE4A0F37-62E7-4342-996D-9DA36CFE2A93Q33320199-EAC6F170-64F6-4B07-97B9-A9F0FDE9DB58Q33337217-2F0C6D1D-3B28-41A8-BC48-372FC8B2A7D7Q33371764-9CB5C9CB-E528-4D9A-9619-576AF279E70EQ33503634-CF6BF243-D120-4AC5-A49B-E3C0FB0589D6Q33507515-6BABE373-A8BA-4538-BE29-AE4F5542FE58Q33576478-3C9886CD-F102-4287-B175-930097811A80Q33586532-D1845F2C-5EE2-4E68-94B9-9818AD6028ABQ33642053-799A77A7-2C7C-4E2C-83E6-0015DAD69D35Q33642887-75EAC148-A67E-44A7-B03F-ED53FF1F1CF4Q33645277-7550A996-B1BC-4C5E-BC79-91DDFD07AA1BQ33645282-DCB36BA9-AAF1-416A-83D0-28E4C58F7B1E
P2860
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Dominant negative mutations in ...... etes mellitus and hypertension
@ast
Dominant negative mutations in ...... etes mellitus and hypertension
@en
Dominant negative mutations in ...... etes mellitus and hypertension
@en-gb
Dominant negative mutations in ...... etes mellitus and hypertension
@nl
type
label
Dominant negative mutations in ...... etes mellitus and hypertension
@ast
Dominant negative mutations in ...... etes mellitus and hypertension
@en
Dominant negative mutations in ...... etes mellitus and hypertension
@en-gb
Dominant negative mutations in ...... etes mellitus and hypertension
@nl
prefLabel
Dominant negative mutations in ...... etes mellitus and hypertension
@ast
Dominant negative mutations in ...... etes mellitus and hypertension
@en
Dominant negative mutations in ...... etes mellitus and hypertension
@en-gb
Dominant negative mutations in ...... etes mellitus and hypertension
@nl
P2093
P50
P921
P3181
P356
P1433
P1476
Dominant negative mutations in ...... etes mellitus and hypertension
@en
P2093
A J Schafer
M Agostini
T D Williams
V E Crowley
V K Chatterjee
P2888
P304
P3181
P356
10.1038/47254
P407
P577
1999-12-01T00:00:00Z
P5875
P6179
1010935612